It is occasionally wrong. In the case by Baker et al. an arteriovenous malformation AND a hypertensive response to pseudoephedrine were responsible for the intracerebral hemorrhage. 1 The exaggerated pharmacological response, in turn, may relate to a hereditary predisposition, invoking a third potential contributor.
2. When the phenomenon is atypical, look more closely. In the case reported by Baker et al., the hemorrhage occurred in the centrum semiovale in a 50 year old man. 1 This site would be atypical for a hypertensive hemorrhage, even if it were druginduced. Most hypertensive hemorrhages occur in the "vascular centrencephalon" (the thalamus, lentiform nuclei, middle pons and cerebellum) where end-arteries bear the brunt of severe hypertension. 3 The patient is too young to have a lobar hemorrhage associated with congophilic angiopathy. Congophilic angiopathy, a disorder of medium sized cerebral arteries with deposition of amyloid in their walls, usually affects individuals over 60 years. 4 Thus one should consider whether there was an abnormal vessel or other condition, e.g., metastasis, predisposed for a hemorrhage in this location at this age. The authors were exemplary in demonstrating this principle. 1 3. Disasters cry out for preventive measures. Several years ago phenylpropanolamine was removed from patent medications when it was found to cause severe hypertensive reactions in normal individuals and intracerebral hemorrhages (ICHs) in persons taking the drug in cold preparations, appetite suppressants or illicit drugs sold as amphetamine look-alikes. 5, 6 Several other sympathomimetics remain in available medications and alternative/herbal remedies. 7 Even though the risk of ICH is very small, if such preparations have widespread use, too many avoidable, devastating strokes will occur each year. Health Canada has moved to ban ephedra compounds from specific drugs. 8 Spontaneous hypertension in the population is much more common than the drug-induced variety; therefore optimal blood pressure control is probably more important in preventing ICH than any other measure. 9 As clinical neuroscientists, we should share in this responsibility.
4. When ICH occurs, steps should be taken to limit the damage. Preliminary evidence indicates that activated factor VII reduces the size of hematomas in primary, hypertensive ICH. 10 It is worth considering that it may also help in hemorrhages related to drug induced-hypertension with or without an underlying vascular malformation.
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